SCHEMBL6563387

SCHEMBL6563387

CC(C)OCCNS(=O)(=O)c1c(Cl)ccc(N)c1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 1/20 0.43
ALDH1A1 P00352 5/20 0.38
TSHR P16473 3/20 0.35
MAPT P10636 2/20 0.35
GSTO1 P78417 1/20 0.35
GLP1R P43220 1/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
RAB9A P51151 1/20 0.34
LMNA P02545 1/20 0.34
MAPK1 P28482 1/20 0.33
CASP3 P42574 1/20 0.33
BLM P54132 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
RECQL P46063 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6565584 0.86 CXCR2 (0.56) CXCR2ALDH1A1TSHRMAPTGSTO1
SCHEMBL6563454 0.84 CXCR2 (0.44) CXCR2ALDH1A1TSHRMAPTGSTO1
SCHEMBL6565726 0.81 CA12 (0.46) CXCR2ALDH1A1TSHRKMT2AMEN1
SCHEMBL6564043 0.81 CXCR2 (0.41) CXCR2ALDH1A1TSHRMAPTKMT2A
SCHEMBL6562115 0.80 GSTO1 (0.43) CXCR2ALDH1A1TSHRMAPTGSTO1
SCHEMBL6565765 0.78 VCAM1 (0.41) CXCR2ALDH1A1TSHRKMT2AMEN1
SCHEMBL6564241 0.78 TSHR (0.50) CXCR2ALDH1A1TSHRKMT2ALMNA
SCHEMBL6563462 0.77 CXCR2 (0.46) CXCR2ALDH1A1LMNASMN1; SMN2HTT
SCHEMBL6564095 0.77 CXCR2 (0.53) CXCR2RAB9ASMN1; SMN2
SCHEMBL27552285 0.77 CXCR2 (0.40) CXCR2ALDH1A1TSHRMAPTGSTO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1161232-B1 HYDROXY DIPHENYL UREA SULFONAMIDES AS IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2004-03-24 EP disclosed
US-20030109527-A1 Hydroxy diphenyl urea sulfonamides as IL-8 receptor antagonists SMITHKLINE BEECHAM CORPORATION 2003-06-12 US disclosed
US-6500863-B1 INTERLEUKIN BINDING INHIBITORS SUCH AS N-(2-HYDROXYL-3-AMINO SULFONYL-4-CHLOROPHENYL)-N'-(2-BROMOPHENYL)UREA, USED FOR PROPHYLAXIS OF CHEMOKINE MEDIATED DISEASES SMITHKLINE BEECHAM CORPORATION 2002-12-31 US disclosed
EP-1161232-A4 HYDROXY DIPHENYL UREA SULFONAMIDES AS IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2002-09-18 EP disclosed
CN-1334726-A Hydroxy diphenyl urea sulfonamides as IL-8 receptor antagonists SMITHKLINE BEECHAM CORP (US) 2002-02-06 CN disclosed
EP-1161232-A1 HYDROXY DIPHENYL UREA SULFONAMIDES AS IL-8 RECEPTOR ANTAGONISTS SmithKline Beecham Corporation (US) 2001-12-12 EP disclosed
WO-2000035442-A1 HYDROXY DIPHENYL UREA SULFONAMIDES AS IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2000-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030109527-A1 Hydroxy diphenyl urea sulfonamides as IL-8 receptor antagonists CXCL8, CCR8, IL18 CXCR2 26/4885ALDH1A1 1321/4885TSHR 1480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.